Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

Michigan Medicine has developed a new technique that provides a non-invasive alternative to surgery, chemotherapy and radiation treatments for cancer.

Early findings of two studies from the University of Michigan Rogel Cancer Center shed light on new ways to anticipate recurrence in HPV-positive head and neck cancer sooner. The papers, published in Cancer and Oral Oncology, offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow, and provide a framework for a new, more sensitive blood test that could help in this monitoring.

Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.

A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

After an awake surgery to remove a cancerous brain tumor, a Michigan man is living “more deliberately” than ever — officiating a high school wrestling state championship and participating in research for a potential cure.

Research, led by Michigan Medicine and the University of Michigan, suggests that glioblastoma cells are poised near a “critical point” of order and disorder — meaning, the cells possess some form of large-scale coordination throughout the whole tumor that allows them to respond in practical unison to attempts to kill tumor cells, such as chemotherapy or radiation.

Research finds genetic testing for cancer can bring more knowledge to patients and their relatives, but not many people get it done.

Researchers at Michigan Medicine have identified a new metric to articulate the relationship between nerve density and oral cancer. The study investigated normalized nerve density to translate previous mechanistic studies into a context that could be used in the clinic.

Financial toxicity of cancer impacts partners’ quality of life, with people reporting pain, fatigue and sleep issues tied to missed work and medical bills

A research partnership has revealed a new pathway to understanding the progression of pancreatic cancer.

A new study finds AI-based diagnostic screening system, DeepGlioma, detects genetic mutations in brain tumors in under 90 seconds. Streamlining glioma diagnosis and treatment.

Protein degrader shows promise against STAT5, which plays a role in leukemia and other cancers